Q&A: The new CEO of biotech’s top trade group on China, vaccines, and Trump

WASHINGTON — BIO’s new CEO John Crowley is making changes.

He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial social issues. He dramatically restructured the organization and laid off around 30 employees to focus on new areas including vaccine education and women’s health.

But as a Republican who’s been floated as a candidate for elected office, his new focus on vaccine education could put him on a collision course with some in his own party. A leaked recording of President Trump this week depicted him expressing skepticism about childhood vaccines.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In